What is the effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease?
A systematic literature review conducted by a European panel of experts found that enzyme replacement therapy (ERT) is an effective treatment for clinical outcomes in male patients with Fabry disease. The review found that ERT can improve clinical outcomes for patients with Fabry disease by reducing pain, improving renal function, and reducing the risk of stroke. Additionally, the review found that ERT can reduce the frequency and severity of flares in patients with Fabry disease.  